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Abstract. 
 
Envoplakin and periplakin are two plakins
that are precursors of the epidermal corniﬁed envelope.
We studied their distribution and interactions by trans-
fection of primary human keratinocytes and other cells.
Full-length periplakin localized to desmosomes, the in-
 
terdesmosomal plasma membrane and intermediate
ﬁlaments. Full length envoplakin also localized to des-
mosomes, but mainly accumulated in nuclear and cyto-
plasmic aggregates with associated intermediate ﬁla-
ments. The envoplakin rod domain was required for
aggregation and the periplakin rod domain was neces-
sary and sufﬁcient to redistribute envoplakin to desmo-
somes and the cytoskeleton, conﬁrming earlier predic-
tions that the proteins can heterodimerize. The linker
domain of each protein was required for intermediate
 
ﬁlament association. Like the NH
 
2
 
 terminus of des-
moplakin, that of periplakin localized to desmosomes;
however, in addition, the periplakin NH
 
2
 
 terminus ac-
cumulated at cell surface microvilli in association with
cortical actin. Endogenous periplakin was redistributed
from microvilli when keratinocytes were treated with
the actin disrupting drug Latrunculin B. We propose
that whereas envoplakin and periplakin can localize in-
dependently to desmosomes, the distribution of en-
voplakin at the interdesmosomal plasma membrane de-
pends on heterodimerization with periplakin and that
the NH
 
2
 
 terminus of periplakin therefore plays a key
role in forming the scaffold on which the corniﬁed en-
velope is assembled.
Key words: envoplakin • periplakin • desmosomes •
corniﬁed envelope • keratinocytes
 
Introduction
 
One important function of mammalian epidermis is to
provide a physical barrier between the body and the envi-
ronment. This function depends on a structure known as
the cornified envelope that is formed in the outermost epi-
dermal layers (Reichert et al., 1993; Simon, 1994; Ishida-
Yamamoto and Iizuka, 1998; Nemes and Steinert, 1999).
The cornified envelope is assembled from a range of pre-
cursor proteins that become cross-linked to one another
through the activity of transglutaminases. The resulting
structure is an insoluble layer of protein with covalently
attached lipid, 
 
z
 
15-nm thick, that is deposited on the in-
ner surface of the plasma membrane.
The most current model of how the cornified envelope
is assembled (Steinert and Marekov, 1999) is based on two
types of data: immunoelectron microscopy of isolated en-
velopes using antibodies to known precursor proteins, and
sequencing of peptides released from envelopes during
controlled sequential proteolysis (Marekov and Steinert,
1998; Steinert and Marekov, 1995, 1997, 1999). An early
step in envelope assembly is transglutaminase-mediated
oligomerization of a precursor known as involucrin. Since
involucrin is a cytosolic protein there must be a mecha-
nism by which it becomes associated with the plasma
membrane. It is believed that this occurs by cross-linking
of involucrin to two proteins, envoplakin and periplakin,
which are found at desmosomes and the interdesmosomal
plasma membrane (Simon and Green, 1984; Ma and Sun,
1986; Ruhrberg et al., 1996, 1997). Subsequent to incorpo-
ration of involucrin, envoplakin, and periplakin into the
envelope, further proteins are added, including small pro-
line-rich proteins, loricrin, and keratin filaments.
Envoplakin and periplakin belong to the plakin family
of cytolinker proteins that also includes desmoplakin,
plectin, and BPAG1 (reviewed by Ruhrberg and Watt,
1997; Fuchs and Cleveland, 1998; Houseweart and Cleve-
land, 1998; Fuchs and Yang, 1999; Herrmann and Aebi,
2000). In addition to being expressed in the epidermis, en-
voplakin and periplakin are found in other stratified epi-
thelia and in two-layered and transitional epithelia such as
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the mammary gland and bladder (Ruhrberg et al., 1996,
1997; Aho et al., 1998). Periplakin is also highly expressed
in brain (Aho et al., 1998). In differentiating keratinocytes
that have not yet assembled a cornified envelope en-
voplakin and periplakin are found at desmosomal plaques,
in close proximity to desmoplakin, in an interdesmosomal
network at the plasma membrane, and associated with
keratin filaments (Ruhrberg et al., 1996, 1997).
All conventional plakins comprise an NH
 
2
 
-terminal glob-
ular domain, a central rod domain and a COOH-terminal
globular domain. More distantly related proteins include
 
Drosophila kakapo 
 
(Stumpf and Volk, 1998; Gregory and
Brown, 1998) and its mammalian homolgue ACF7 (Leung
et al., 1999; Karakesisoglou et al., 2000), which share ho-
mology with plakins at the NH
 
2
 
 terminus and with dystro-
phin at the COOH terminus. The NH
 
2
 
-terminal domain is
known to direct desmoplakin and plectin to membrane lo-
calization sites (desmosomes and hemidesmosomes, re-
spectively) (Bornslaeger et al., 1996; Smith and Fuchs,
1998; Wiche, 1998; Geerts et al., 1999). Plectin and some al-
ternatively spliced variants of BPAG1 have, in addition, an
NH
 
2
 
-terminal actin binding domain (Yang et al., 1996; Liu
et al., 1996; Andrä et al., 1998; Fuchs et al., 1999). One of
the BPAG1 isoforms has an NH
 
2
 
-terminal microtubule
binding site (Yang et al., 1999) and plectin interacts with
microtubules, probably via microtubule-associated proteins
(Svitkina et al., 1996; Wiche, 1998). The central rod domain
forms a coiled coil structure that mediates assembly of
plakins into parallel homodimers (Green et al., 1990, 1992;
Wiche et al., 1991; Sawamura et al., 1991) and the COOH-
terminal globular domains of desmoplakin, plectin, and
BPAG1 bind intermediate filaments (Foisner et al., 1988;
Stappenbeck and Green, 1992; Stappenbeck et al., 1993;
Wiche et al., 1993; Kouklis et al., 1994; Nikolic et al., 1996;
Yang et al., 1996; Steinböck et al., 2000).
Although periplakin and envoplakin share the overall
structure of desmoplakin, plectin, and BPAG1, their
COOH-terminal domains, are considerably smaller, with
envoplakin having only one of the globular subdomains
(the C box) and periplakin none (Ruhrberg et al., 1996,
1997; Aho et al., 1998). The COOH termini of envoplakin
and periplakin do, however, include the recently defined
linker motif, which is the region of highest sequence ho-
mology between all family members (Ruhrberg et al., 1997;
Ruhrberg and Watt, 1997; Aho et al., 1998; Mahoney et al.,
1998; Määttä et al., 2000). This motif comprises the entire
COOH terminus of periplakin and in other plakins lies
NH
 
2
 
-terminal to the final COOH-terminal globular subdo-
main (the C box); it includes all but 7 of the 50 amino acids
that in plectin comprise the intermediate filament binding
site (Nikolic et al., 1996; Mahoney et al., 1998). In addi-
tion to their small COOH-terminal domains a notable dif-
ference between periplakin, envoplakin, and the other
plakins is that their rod domain sequences predict that het-
erodimer formation would be energetically favorable; indi-
rect support for heterodimer formation comes from the
observation that the two proteins coimmunoprecipitate
under stringent buffer conditions (Ruhrberg et al., 1997).
Given the proposed role of envoplakin and periplakin as
the scaffold on which the cornified envelope is assembled
and their divergence (Ruhrberg et al., 1997; Määttä et al.,
2000) from other members of the plakin family, we decided
to investigate what determines their subcellular distribu-
tion and interactions. We have analyzed the full-length pro-
 
teins and their individual domains by stable and transient
transfection of primary human keratinocytes and other cell
types. We demonstrate a key role for periplakin in direct-
ing the subcellular distribution of both proteins and, specif-
ically, for the NH
 
2
 
 terminus of periplakin in targeting the
proteins to the interdesmosomal plasma membrane.
 
Materials and Methods
 
Generation of cDNA Constructs
 
Plasmids containing partial cDNAs (Ruhrberg et al., 1996, 1997) for both
envoplakin and periplakin were used to create full-length cDNAs by using
unique restriction enzyme digests to allow fusion of multiple cDNA frag-
ments and assembly into pBluescript II KS
 
1
 
/
 
2
 
 (Stratagene). The full-
length cDNAs were then tagged with either influenza virus hemagglutinin
(HA
 
1
 
; periplakin) or FLAG (envoplakin) protein coding sequences in a
PCR reaction using primers that linked the epitope tags in frame with the
plakin cDNAs at the COOH-terminal ends. Subsequently, the new
COOH-terminal fragments were ligated to the cDNA in pBluescript and
the resulting tagged cDNA was subcloned into pCI-neo, a mammalian ex-
pression vector from Promega. The primers used were: AGGCCCTC-
CTCTCCGGGATGATCAGTGAAGA (envoplakin COOH terminus,
5
 
9
 
 end); GCTCTAGAGCTCACTTGTCATCGTCGTCCTTGTAGT-
CGCGAAGGGAGCGCGGGACGGTGGGGGAGGCGGAGCGGTA
(envoplakin COOH-terminal FLAG tag, 3
 
9
 
 end); AAGGTAACCCAT-
ACGCAGAAGGTGGTGCTGCA (periplakin COOH terminus, 5
 
9
 
end); CCAAGCTTGGGTCTAGAGCGGCCGCCTAAGCGTAGTCT-
GGCACGTCGTATGGGTACTTCTGCCCAGATACCAAGACCGCA
(periplakin COOH-terminal HA tag, 3
 
9
 
 end).
All truncated periplakin cDNAs were constructed by PCR amplifica-
tion from the full-length cDNA linking the epitope tag to the mutant
cDNA in frame at either the NH
 
2
 
-terminal or COOH-terminal end (see
Fig. 1). Primers for generating the periplakin cDNA fused with the HA
epitope tag were as follows: 5
 
9
 
-GACCGAGTCGACCTACGCATAG-
TCAGGAACATCGTATGGGTAATTCTCGGTCTTCAGCACCTC-
ATACCGCTGCT (P-1/2N); 5
 
9
 
-AAGACGAATTCGCCGCCACCA-
TGTACCCATACGATGTTCCTGACTATGCGCAGAAGCGCCTG-
GGCTCC (P-C); 5
 
9
 
-GACCGAGTCGACCTACGCATAGTCAGGA-
ACATCGTATGGGTAGACGGCCACGGAGCCCAGGCGCTT (P-R
and P-NR); 5
 
9
 
- GTGCTCAAGAATTCAGCCACCATGTACCCA-
TACGATGTTCCTGACTATGCGCAGGAATCGGTGGTGAGGAA-
GGAGGTGCT (P-RC).
All the envoplakin partial cDNAs except for E-NR and E-RC (see Fig.
1) were assembled using PCR reactions to amplify targeted sequences
which were then subcloned in frame into a modified pCI-neo vector (F9).
F9 was created by inserting the FLAG epitope into the SmaI site of the
pCI multicloning region, flanked by an ATG start site, a TAG termination
codon sequence, and interior SmaI and EcoRV restriction sites. The
FLAG oligomers were: 5
 
9
 
-GAGGATGACGCCACCATGGATATC-
GACTACAAGGACGACGATGACAAGCCCGGGTAGATTTCT-
GCT-3
 
9
 
 and 5
 
9
 
-AGCAGAAATCTACCCGGGCTTGTCATCGTCG-
TCCTTGTAGTCGATATCCATGGTGGCGGCGTCATCCTC-3
 
9
 
. The
envoplakin primers were designed according to the human envoplakin
cDNA sequence (GenBank/EMBL/DDBJ accession number U53786),
and began and ended at the amino acid residues indicated in Fig. 1.
The envoplakin mutant containing the NH
 
2
 
 terminus and rod domain
(E-NR) was constructed by digestion of the full-length envoplakin cDNA
with EcoRI followed by partial digestion with BglII. The resultant frag
ment was then subcloned into F9 using EcoI and EcoRV, placing the
FLAG sequence at the COOH-terminal end.
The E-RC construct was assembled with PCR amplification of the en-
voplakin cDNA using the following primers: 5
 
9
 
-ATGGCCCAAGCAGG-
GAGAGAGTCAGAG (5
 
9
 
 end) and 5
 
9
 
-GCGATTTGGCTTTCTG-
GAGGACGTCAAT (3
 
9
 
 end). The resulting fragment was digested at the
unique AatII restriction site and ligated to the full-length FLAG-tagged
envoplakin cDNA, which had previously been digested with HindIII and
AatII to remove sequences encoding the NH
 
2
 
 terminus. The resulting
E-RC construct was then subcloned into pCI-neo.
 
1
 
Abbreviations used in this paper: 
 
FAD, Ham’s F12 medium 
 
1
 
 adenine
 
1
 
DME; FGS, fish skin gelatin; HA, hemagglutinin; HICE, hydrocortisone 
 
1
 
insulin 
 
1
 
 cholera toxin 
 
1
 
 EGF; KSFM, keratinocyte serum-free medium.  
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Cells and Cell Lines
 
Normal human keratinocytes (strains km, kp, and kq) isolated from new-
born human foreskin were maintained in the presence of mitomycin
C–treated 3T3 feeder cells in FAD (one part Ham’s F12 to three parts
DME, supplemented with 1.8 
 
3 
 
10
 
2
 
4
 
 M adenine) medium supplemented
with 10% FCS (Imperial Laboratories) and HICE cocktail, consisting of 0.5
 
m
 
g/ml hydrocortisone, 5 
 
m
 
g/ml insulin, 10
 
2
 
10
 
 M cholera toxin, and 10 ng/ml
epidermal growth factor (Ruhrberg et al., 1996, 1997). An HPV16-trans-
formed line of human keratinocytes, vp (Pei et al., 1991), and a spontane-
ously immortalized line of adult mouse keratinocytes, MKneg (Romero et
al., 1999), were grown in FAD
 
 1 
 
FCS
 
 1
 
 HICE without a feeder layer.
A431 (human epidermoid carcinoma), COS7 (African green monkey
kidney), NIH and Swiss 3T3 (mouse embryonic fibroblasts), SCC-13 (hu-
man squamous cell carcinoma), and HeLa (human cervical carcinoma)
cell lines were maintained in DME supplemented with 10% FCS. SW13-
1.1 and 1.2 clones (Sarria et al., 1994) were cultured in FAD medium sup-
plemented with 5% FCS; clone 1.2 was maintained under selection in 500
 
m
 
g/ml G418 (Sigma-Aldrich).
 
Transient Transfection
 
Two different methods were used to transiently transfect cells, each of
which gave the same results. In the first method primary human kerati-
nocytes were seeded on coverslips at a density of 7.5 
 
3
 
 10
 
5
 
 cells/well in a
six-well plate in FAD 
 
1 
 
FCS 
 
1 
 
HICE for 3 h. Nonadherent cells were re-
moved by washing twice in PBS and adherent cells were cultivated in ke-
ratinocyte serum-free medium (KSFM; GIBCO BRL) overnight. The
next day, the medium was replaced with transfection reaction mix and in-
cubated for 2 h. The cells were then cultivated in KSFM for 16 h, after
which time the medium was replaced with FAD 
 
1 
 
FCS 
 
1 
 
HICE for a fur-
ther 5 or 24 h. The transfection reaction mix consisted of Fugene 5 (Boeh-
ringer) or Superfect (QIAGEN) lipofection reagent, combined with se-
rum-free DME and 2 
 
m
 
g of the relevant plasmid DNA, according the
manufacturer’s protocol. A431, SCC-13, 3T3, and HeLa cells were trans-
fected in their normal culture media with Fugene 5 the day after plating at
densities of 3–4 
 
3
 
 10
 
5
 
 cells per well and fixed 24 h later.
In the second method primary human keratinocytes were adapted to
KSFM without feeders for one passage before transfection. The day be-
fore transfection, keratinocytes were seeded on coverslips in 24-well plates
at a density of 5 
 
3
 
 10
 
4
 
 cells/well. The keratinocytes were treated with
transfection reaction mixture for 1–2 h, washed with PBS, and transferred
to FAD 
 
1 
 
FCS 
 
1 
 
HICE for 24 h. The transfection mixture consisted of
Superfect reagent (QIAGEN) combined with KSFM and plasmid DNA,
according the manufacturer’s protocol. For transfection of HeLa, COS7
and NIH3T3 cells serum-free DME was used instead of KSFM.
 
Establishment of Stably Transfected Cell Lines
 
A well-differentiated, spontaneously immortalized line of keratinocytes de-
rived from adult mouse epidermis (MKneg cells) (Romero et al., 1999) was
adapted to growth in KSFM. The cells were transfected with Superfect con-
taining full-length FLAG-tagged envoplakin or full-length HA-tagged
periplakin in pCI-neo. 72 h after transfection cells were transferred to se-
lection medium containing 0.5 mg/ml G418 (GIBCO BRL). G418-resistant
colonies were isolated using cloning rings and transferred to 24-well plates.
A total of 48 clones transfected with the envoplakin construct and 10 clones
transfected with the periplakin construct were screened by immunofluores-
cence with anti-FLAG or anti-HA antibodies. Positive clones (five express-
ing envoplakin; two expressing periplakin) were expanded and maintained
in KSFM or FAD 
 
1 
 
FCS 
 
1 
 
HICE containing 0.5 mg/ml G418.
 
Immunofluorescence Staining
 
The following primary antibodies were used: 11-5F (mouse monoclonal
antibody to desmoplakin; gift of David Garrod, University of Manchester,
Manchester, UK), DPI/II (mouse monoclonal antidesmoplakin; ICN Bio-
medicals), CR3 and CR5 (rabbit antibodies to periplakin and envoplakin,
respectively; Ruhrberg et al., 1997), AE11 (mouse monoclonal antibody to
periplakin; gift of Henry Sun, New York University Medical School, New
York, NY; Ma and Sun, 1986), LP34 (mouse monoclonal antikeratins 5, 6,
18; Lane et al., 1985), LL001 (mouse monoclonal antibody to keratin 14;
Lane, 1982), 13.2 (mouse monoclonal antivimentin; Sigma-Aldrich), V9
(mouse monoclonal antivimentin; Novocastra), rabbit antigiantin (a gift of
David Shima, Imperial Cancer Research Fund), goat antitransferrin recep-
tor (Santa Cruz Biotechnology, Inc.), AF8 (mouse monoclonal antibody to
calnexin; gift of M.B. Brenner, Brigham and Women’s Hospital, Harvard
Medical School, Boston, MA; Hochstenbach et al., 1992), 1D3 (rabbit anti-
protein disulphide isomerase; gift of S. Fuller, EMBO, Heidelberg, Ger-
many; Huovila et al., 1992), TUB 1A2 (mouse monoclonal antibody to
 
b
 
-tubulin; Sigma-Aldrich), rabbit anti-HA (Y11; Santa Cruz Biotechnol-
ogy, Inc.), rabbit anti-FLAG (Santa Cruz Biotechnology, Inc.), M2 (mouse
monoclonal anti-FLAG; Kodak), and mouse monoclonal antilamin B2
(Novocastra). Alexa 488– or Alexa 594–conjugated goat anti–rabbit or
–mouse IgG (Molecular Probes) were used as secondary antibody. In
some experiments M2 and LP34 were directly conjugated to Alexa 488 and
Alexa 594 fluorophores, respectively. When two different antibodies were
used to detect the same protein by immunofluorescence they gave similar
staining patterns.
Cells on coverslips were fixed in 3–4% paraformaldehyde for 20 min at
room temperature or in methanol/acetone 1:1 on ice or at 
 
2
 
20
 
8
 
C for 5
min. Paraformaldehyde fixation gave optimal preservation of membrane-
associated antigens, whereas cytoskeletal antigens were optimally visual-
Figure 1. Constructs used for transfection. Do-
main nomenclature is as described by Ruhrberg
et al. (1996, 1997). L, linker domain; a.a, amino
acid; HA, influenza virus hemagglutinin. 
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ized after methanol/acetone fixation. Paraformaldehyde-fixed cells were
permeabilized with 0.1–0.2% Triton X-100 for 5 min at room temperature.
In some experiments cells were incubated with 200 ng/ml Latrunculin B
(Calbiochem-Novabiochem) for 3 h at 37
 
8
 
C before fixation. After fixation
cells were washed thoroughly in PBS or PBSABC and blocked in 0.2%
fish skin gelatin (Sigma-Aldrich) or a 1:500 dilution of goat serum in PBS.
Cells were incubated with primary antibodies for 45 min at room tempera-
ture or with FITC-conjugated phalloidin (to visualize F-actin) for 10 min
at room temperature, washed in PBS or PBSABC, and then incubated for
a further 45 min at room temperature with the appropriate Alexa conju-
gated secondary antibodies. After further washing in PBS or PBSABC
coverslips were mounted in Gelvatol (Monsanto) and examined using an
Axiophot Microscope (Carl Zeiss, Inc.) or a laser scanning confocal mi-
croscope (LSM 510; Carl Zeiss, Inc.). Digital images were prepared using
Adobe Photoshop 5.0.
 
Electron Microscopy and Immunogold Labeling
 
For conventional transmission EM, keratinocytes were grown to conflu-
ence on 6-cm tissue culture dishes, and then detached as an intact sheet by
incubation with 50 mg/ml Dispase II (Boehinger) in serum-free FAD at
37
 
8
 
C for 5 min. The sheets were washed in PBS and collected as a pellet by
centrifugation. The pellet was fixed in glutaraldehyde and processed as
described previously (Gandarillas et al., 1999).
For immunogold labeling, cell pellets prepared as described above
were transferred to a BalTec high pressure freezing apparatus for cryofix-
ation at a pressure of 2,500 bar and temperature of 
 
2
 
170
 
8
 
C (Studer et al.,
1989). The frozen specimens were freeze-substituted in anhydrous ace-
tone containing 0.5% uranil acetate and kept at 
 
2
 
90
 
8
 
C in freeze-substitu-
tion medium for 72 h. The temperature was incrementally raised to 
 
2
 
45
 
8
 
C
using the Bal-Tec freeze-substitution apparatus. Specimens were washed
in anhydrous acetone and embedded in Lowicryl HM20 resin at
 
 2
 
45
 
8
 
C
with UV polymerization for 48 h.
Ultrathin sections of cell sheets were mounted on carbon-coated grids
and labeled as follows. After 10 min incubation on a drop of PBS, the
grids were blocked in 0.05% fish skin gelatin in PBS (FGS/PBS) for 30
min, and then labeled with rabbit anti-FLAG or anti-HA antibody over-
night at 4
 
8
 
C. The sections were washed with 0.05% FGS/PBS and then la-
beled with a 1:65 dilution of protein A conjugated to 10 nm gold (J.W.
Slot, Cell Biology Department, University of Utrecht, Netherlands) in
0.05% FGS/PBS for 30 min. After further washing in PBS and distilled
water the sections were air-dried and contrasted with saturated aqueous
uranyl acetate and lead citrate. As a negative control the primary anti-
body was omitted. For double labeling, sections were first labeled with the
anti-FLAG antibody followed by 5 nm protein A gold and then with LP34
antibody followed by 10 nm gold-conjugated goat anti–mouse IgG (Bio
Cell International, Cardiff, UK) (Slot et al., 1991). Thin sections were ex-
amined with a Jeol EM1200 or EM1010 electron microscope.
 
Results
 
Full-length Envoplakin Forms Nuclear and 
Cytoplasmic Aggregates
 
Transfection of full-length, FLAG-tagged envoplakin
cDNA (Fig. 1) into primary human epidermal kerati-
nocytes resulted in the formation of prominent nuclear and
cytoplasmic aggregates (Fig. 2, a–d, i, and j), with only a
small proportion of the tagged protein accumulating at
Figure 2. Transient transfection of full-length FLAG-tagged envoplakin into primary human keratinocytes (a–d, i, and j), COS7 cells (e–h),
SW13-1.1 (k), and SW13-1.2 (l) cells. Green fluorescence: anti-FLAG. Red fluorescence: antikeratin (LP34) (a, b, i, and j); antilamin B (c
and d); antivimentin (e, g, and h). Bar, 10 mm. Areas boxed in a, c, e, and i are shown at higher magnification in b, d, f–h, and j, respectively. 
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Figure 3. Electron micrographs of transiently transfected primary human keratinocytes (a and b) and stably transfected mouse keratinocytes
(c and d). Cells were transfected with FLAG-tagged full-length envoplakin (a–c) or HA-tagged full-length periplakin (d). (a and b) Conven-
tional transmission EM: (b) corresponds to boxed area in a. (c and d) Immunoelectron microscopy with antibodies to FLAG (c) or HA (d).
Bars: (a) 1 mm; (b) 500 nm; (c and d) 200 nm. 
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cell–cell borders. Aggregates were observed in both basal
and involucrin-positive keratinocytes and in standard and
low calcium medium (data not shown). Envoplakin aggre-
gates were also observed when untagged full-length en-
voplakin was expressed, ruling out a potential contribution
of the FLAG tag (data not shown). Aggregates formed in
all cell types transfected: the human keratinocyte-derived
tumor lines SCC13, HeLa, and A431, HPV16-immortalized
human keratinocytes (vp), a well differentiated mouse ke-
ratinocyte line (MKneg), COS7 cells, and NIH and Swiss
3T3 mouse embryo fibroblasts (Fig. 2 and data not shown).
Envoplakin aggregates were not labeled with antibodies
to markers of the Golgi (giantin), endosomes (transferrin re-
ceptor), endoplasmic reticulum (calnexin), or lysosomes
(protein disulphide isomerase) (data not shown). However,
cytoplasmic aggregates stained positive with antibodies to
keratin filaments in epithelial cells (Fig. 2, a and b) and to vi-
mentin in fibroblasts and COS7 cells (Fig. 2, e–h). Nuclear
aggregates were labeled with antibodies to lamin B2 (Fig. 2,
c and d). In all cell types except primary keratinocytes all ag-
 
gregates labeled with antibodies to intermediate filaments;
however, in keratinocytes heterogeneity was observed, with
aggregates in occasional cells being unlabeled (compare Fig.
2, a and b with i and j). The absence of keratin labeling did
not show a simple correlation with the differentiation status
of the cells since aggregates were labeled with the pan-kera-
tin antibody LP34 (which recognizes keratins 5, 6, and 18)
and with monospecific antibodies to keratin 14 (expressed
by basal keratinocytes) and keratin 6 (expressed by differen-
tiating keratinocytes in hyperproliferative epidermis) (Fig.
2, a and b and data not shown).
To determine whether aggregate formation required the
presence of cytoplasmic intermediate filaments full-length
FLAG-tagged envoplakin was transfected into two clones
of the human adrenal tumor cell line SW13 (Sarria et al.,
1994). Aggregates were observed in both the vimentin-
positive SW13-1.1 clone (Fig. 2 k) and the vimentin-nega-
tive SW13-1.2 clone (Fig. 2 l), indicating that aggregate
formation occurred independently of an intermediate fila-
ment cytoskeleton.
To further analyze the envoplakin aggregates, tran-
siently transfected primary human keratinocytes (Fig. 3, a
and b) and stably transfected mouse keratinocytes (Fig. 3
c) were examined by conventional and immunoelectron
microscopy. Transiently transfected cells were character-
ized by bundles of keratin filaments within which were
trapped large numbers of cytoplasmic vesicles; in some
cells the nuclear membrane appeared to be disrupted (Fig.
3, a and b). When ultrathin cryosections were incubated
with anti-FLAG antibodies and protein A gold the keratin
filaments were specifically labeled (data not shown).
In contrast to the aggregates in transiently transfected
cells (Fig. 2; Fig. 3, a and b) most of the aggregates in sta-
bly transfected keratinocytes were small. It is therefore
likely that cells containing large aggregates did not survive
or failed to divide. In stably transfected keratinocytes full-
length envoplakin was localized both to small aggregates
and to the plaques of desmosomes (Fig. 3 c and data not
shown). We conclude that although much of the en-
voplakin expressed in transfected cells formed aggregates
full-length envoplakin did have the ability to incorporate
into desmosomes, in the same location as the endogenous
protein (Fig. 3 c; compare Ruhrberg et al., 1996).
 
The Envoplakin Rod Domain Is Required for
Aggregate Formation
 
To investigate the domains of envoplakin responsible for
aggregation we transiently transfected cells with the partial
envoplakin constructs illustrated in Fig. 1. Nuclear and cy-
toplasmic aggregates formed when the COOH-terminal C
box and all but 11 amino acids of the linker domain were
deleted (Fig. 4, a and b) or when the NH
 
2
 
 terminal domain
was deleted (Fig. 4, c and d). In each case the aggregates
stained positive with antibodies to intermediate filaments
(keratins in epithelial cells; vimentin in 3T3 cells) (Fig. 4, a–d
and data not shown). Thus the association of the aggregates
with intermediate filaments occurred in the absence of ei-
ther the NH
 
2
 
 terminus or the C box of envoplakin.
The first 500 amino acids of the NH
 
2
 
 terminus (E-1/2N)
and the COOH-terminal C box of envoplakin did not form
aggregates. The E-1/2N construct, corresponding to the
region of desmoplakin required to target desmosomes
Figure 4. Transient transfection of primary human kerati-
nocytes with different domains of envoplakin. E-NR (a and b);
E-RC (c and d); E-1/2N (e); E-C (f). Green fluorescence: anti-
FLAG. Red fluorescence: antikeratin (LP34). The same fields
of cells are shown in a and b and in c and d. Arrows in a–d show
the positions of individual envoplakin aggregates and associ-
ated intermediate filaments. Bar: (a and b) 9.3 mm; (c and d) 5
mm; (e) 4 mm; (f) 4.4 mm. 
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(Bornslaeger et al., 1996), was diffusely distributed in the
cytoplasm (Fig. 4 e). The C box was also distributed
throughout the cytoplasm, but in a punctate pattern (Fig. 4
f). We conclude that aggregation required the rod domain
of envoplakin. Neither the NH
 
2
 
 terminus nor C box in iso-
lation showed any strong association with the cytoskeleton
and there was no evidence that either construct accumu-
lated at desmosomes (Fig. 4, e and f).
 
Full-length Periplakin Associates with Desmosomes 
and Keratin Filaments
 
When HA-tagged full-length periplakin was transiently
transfected into primary human keratinocytes the protein ac-
cumulated on the apical plasma membrane and at cell–cell
contacts (Fig. 5, a and b). In cells expressing high levels of the
protein there was additional filamentous cytoplasmic staining
(Fig. 5, c and d) with, in some cells, bundling and partial col-
lapse of the keratin filament network (data not shown). Dou-
ble labeling with antidesmoplakin revealed partial colocaliza-
tion of periplakin with desmosomal junctions (Fig. 5, e and f)
and this was confirmed by immunoelectron microscopy of
mouse keratinocytes stably transfected with full-length HA-
tagged periplakin (Fig. 3 d). Cytoplasmic periplakin showed
partial colocalization with keratin filaments in keratinocytes,
particularly at points of insertion of keratin filaments into
desmosomes (Fig. 5, c and d; Fig. 3 d). In COS7 cells
periplakin showed partial colocalization with vimentin fila-
ments (Fig. 5, g and h). The distribution of untagged full-
length periplakin in transiently transfected cells was the same
as that of the HA tagged protein (data not shown).
 
Periplakin Rescues Envoplakin from Aggregates
 
Envoplakin and periplakin are coimmunoprecipitated
from keratinocyte lysates and analysis of their rod domain
 
sequences suggests that heterodimerization would be en-
ergetically favorable (Ruhrberg et al., 1997). To examine
potential interactions between the two proteins we investi-
gated whether cotransfection of envoplakin with peri-
plakin would prevent envoplakin from forming aggre-
gates. The following molar ratios of periplakin to
envoplakin cDNAs were transfected into keratinocytes:
10:1, 5:1, 2:1, 1:1, 1:2, 1:5, and 1:10. When coexpressed at a
molar ratio of 1:1 or greater the two proteins showed ex-
tensive colocalization (Fig. 6, a–c and data not shown). No
envoplakin aggregates were observed and instead both
proteins had a filamentous distribution throughout the cy-
toplasm (Fig. 6, a–e, i, and j), with some concentration at
cell–cell borders (Fig. 6, d, e, i, and j). The cytoplasmic
staining showed partial colocalization with keratin fila-
ments (Fig. 6, d and e) and the cell–cell border staining
showed partial colocalization with desmoplakin (Fig. 6, i
and j). The distribution of periplakin in cells cotransfected
with envoplakin was the same as that in cells transfected
with periplakin alone (compare Figs. 5 and 6; and data not
shown). When the molar ratio of periplakin to envoplakin
fell below 1 envoplakin aggregates were observed (data
not shown). We conclude that the two proteins interact
and that the 1:1 ratio of cDNAs required for periplakin to
rescue envoplakin would be consistent with envoplakin–
periplakin heterodimer formation.
To map the domain of periplakin that was required to
prevent full-length envoplakin from aggregating a series of
partial periplakin constructs were cotransfected into pri-
mary keratinocytes in combination with envoplakin. Trans-
fection of a 1:1 molar ratio of envoplakin with the
periplakin NH
 
2
 
 terminus 
 
1
 
 rod (P-NR), rod 
 
1
 
 COOH ter-
minus (P-RC), or rod alone (P-R) prevented aggregate for-
mation (Fig. 1; Fig. 6, f–h and data not shown). However,
aggregates did form when envoplakin was cotransfected
Figure 5. Transient transfection of full-length HA-tagged periplakin into primary human keratinocytes (a–f) and COS7 cells (g and h).
Green fluorescence: anti-HA. Red fluorescence: antikeratin (LP34) (a–d); antidesmoplakin (e and f); antivimentin (g and h). Bar: 10
mm. Areas boxed in a, c, e, and g (composite images) are shown at higher magnification as 0.2–0.5mm slices in b, d, f, and h, respectively. 
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with the periplakin 1/2 NH
 
2
 
 terminus (data not shown). We
conclude that the rod domain of periplakin is necessary and
sufficient to prevent envoplakin from forming aggregates.
 
Periplakin NH
 
2
 
 Terminus Localizes at the Plasma 
Membrane and COOH Terminus Associates with 
Keratin Filaments
 
To examine which domains of periplakin mediated the as-
sociation with the plasma membrane and cytoskeleton we
tested a series of periplakin deletion constructs (Fig. 1) by
transient transfection of primary human keratinocytes. A
construct in which the COOH terminus was deleted local-
ized to the plasma membrane in a punctate distribution
(Fig. 7 a). The same distribution was observed when the 1/2
NH
 
2
 
 terminus of periplakin (again corresponding to the
region of desmoplakin shown to target to desmosomes;
Bornslaeger et al., 1996) was transfected (Fig. 7 b). In con-
trast, the COOH terminus of periplakin showed a filamen-
tous distribution throughout the cytoplasm (Fig. 7 c). The
1/2 NH
 
2
 
 terminus of periplakin showed limited colocaliza-
tion with desmoplakin at cell–cell borders, but periplakin
 
was also extensively localized to the free apical mem-
branes of keratinocytes, where desmosomes are absent
(Fig. 7 b). When the 1/2 NH
 
2
 
 terminus of periplakin and
the 1/2 NH
 
2
 
 terminus of desmoplakin (Bornslaeger et al.,
1996) were cotransfected there was colocalization of both
constructs at individual desmosomes and no evidence that
either construct affected the distribution of the other (data
not shown). We conclude that the periplakin NH
 
2
 
 termi-
nus targets the protein to the plasma membrane, including
desmosomes, whereas the COOH terminus mediates the
interaction with keratin filaments.
 
Periplakin NH
 
2 
 
Terminus Associates with the Cortical 
Actin Cytoskeleton
 
The punctate apical distribution of the periplakin 1/2 NH
 
2
 
-
terminal construct was reminiscent of the short microvilli
of keratinocytes in medium with a calcium ion concentra-
tion of 
 
.
 
1 mM (Morrison et al., 1988) (Fig. 8 a). The mi-
crovillar association was more pronounced in A431 cells,
which have longer microvilli than keratinocytes (Fig. 8 b).
There was extensive colocalization of the 1/2 NH
 
2
 
 termi-
Figure 6. Transient cotransfection of primary human keratinocytes with full-length FLAG-tagged envoplakin and full-length HA-
tagged periplakin (a–e, i, and j) or the periplakin rod domain (P-R; f–h). Green fluorescence: anti-FLAG. Red fluorescence: anti-HA
(b, c, g, and h); antikeratin (LP34; d and e); antidesmoplakin (i and j). Panels a–c and f and g show the same cells. Bar: (a–c) 7.5 mm, (d
and i) 10 mm, (f–h) 12 mm. Areas boxed in panels d and i are shown at higher magnification in e and j, respectively.
Figure 7. Transient transfection of primary human keratinocytes with different HA-tagged domains of periplakin. (a and c) Green flu-
orescence: anti-HA. (b) Red fluorescence: anti-HA; green fluorescence: antidesmoplakin. Bar: (a and b) 9 mm; (c) 11 mm.DiColandrea et al. Distribution of Envoplakin and Periplakin 581
nus of periplakin and actin at the apical plasma membrane
(Fig. 8 c). When cells were treated with Latrunculin B to
depolymerize F-actin the periplakin construct redistrib-
uted with the actin (Fig. 8, d and e).
We next examined whether endogenous periplakin was
associated with the actin cytoskeleton. Periplakin in kera-
tinocytes was concentrated both at cell–cell borders, as re-
ported previously (Ruhrberg et al., 1997), and in a punc-
tate distribution on free apical membranes (Fig. 9 a).
Endogenous periplakin showed extensive colocalization
with polymerized actin (Fig. 9, a–c). In keratinocytes, La-
trunculin B caused collapse of the actin cytoskeleton into
actin-rich spots and resulted in a corresponding redistribu-
tion of endogenous periplakin (Fig. 9, d–f), even though
the keratin filament network remained intact (data not
shown; Spector et al., 1999). A different actin depolymer-
izing drug, cytochalasin D, also caused redistribution of
periplakin (data not shown). In contrast, the distribution
of desmoplakin was not affected by Latrunculin B treat-
ment (Fig. 9, g–i).
Discussion
Our earlier immunofluorescence and immunoelectron mi-
croscopy studies placed envoplakin and periplakin at the
desmosomal plaque, at the interdesmosomal plasma mem-
brane and in association with keratin filaments in termi-
nally differentiating keratinocytes (Ruhrberg et al., 1996,
1997). We now show that on transfection full-length
periplakin goes to all of these locations independently of
envoplakin. In the absence of transfected periplakin some
envoplakin localizes to desmosomes, but most ends up in
large cytoplasmic and nuclear aggregates. We confirm our
previous prediction that the two proteins can interact via
their rod domains and show that periplakin associates with
cortical actin via its NH2 terminus, thereby suggesting how
envoplakin and periplakin can localize to the interdesmo-
somal plasma membrane, a key requirement for their scaf-
folding role during cornified envelope assembly (Steinert
and Marekov, 1999).
All plakins are believed to form two-stranded, in reg-
ister parallel homodimers (O’Keefe et al., 1989; Tang
et al., 1996; Ruhrberg and Watt, 1997), but envoplakin
and periplakin are unique in that both homo- and het-
erodimers are predicted to be energetically stable (Ruhr-
berg et al., 1997). We found that cotransfection of equimo-
lar concentrations of full-length periplakin and envoplakin
prevented envoplakin from accumulating in aggregates.
Aggregation was dependent on the presence of the en-
voplakin rod domain, and the rod domain of periplakin
was sufficient to prevent envoplakin from aggregating.
Aggregates still formed when the NH2 or COOH terminus
of envoplakin was deleted and this would imply a role for
the rod domain in higher order complex formation, as re-
ported for other plakins. Plectin, for example, may assem-
ble as a homotetramer composed of two parallel dimers
arranged antiparallel and overlapping along their entire
length (Wiche et al., 1991; Svitkina et al., 1996; Ruhrberg
and Watt, 1997; but see also Wiche, 1998).
The envoplakin aggregates are most likely an artifact of
the high levels of expression achieved in transiently trans-
fected cells, but do, nevertheless, provide useful informa-
tion about the interaction of envoplakin with intermediate
filaments. The aggregates were labeled with antibodies to
keratins characteristic of simple and stratified epithelia, to
vimentin and lamin B2, thus demonstrating an ability
to interact with diverse intermediate filament types, as re-
ported for plectin (Wiche et al., 1993; reviewed by Wiche,
Figure 8. Transient transfection of the NH2-terminal domain of periplakin (P-1/2N, HA tagged) into primary human keratinocytes (a
and c–e) or A431 cells (b). Red fluorescence: anti-HA. Green fluorescence: phalloidin-FITC. Cell in panel e was treated with Latruncu-
lin B (200 ng/ml, 3 h) before fixation. Bars: (a) 13 mm; (b) 6.3 mm; (c) 4.3 mm; (d and e) 4.5 mm.The Journal of Cell Biology, Volume 151, 2000 582
1998). Part of the intermediate filament binding domain of
plectin is a functional nuclear localization signal (Nikolic
et al., 1996) and there is a potential nuclear localization
signal in the linker domain of envoplakin (data not
shown). Desmoplakin can also interact with a range of in-
termediate filaments, but shows a preferential association
with type II epidermal keratins (Kouklis et al., 1994; Meng
et al., 1997). Envoplakin aggregates did not associate with
microtubules (data not shown), although such interactions
have now been established for plectin and certain BPAG1
isoforms (Svitkina et al., 1996; Wiche, 1998; Yang et al.,
1999). Envoplakin aggregates were not dependent on in-
termediate filaments and aggregate formation by trun-
cated constructs (E-NR, E-RC) was independent of full-
length envoplakin or periplakin since it occurred in 3T3
cells. Full-length periplakin associated with keratin and vi-
mentin filaments.
The intermediate filament binding region of plectin has
been mapped to 50 amino acids linking the COOH-termi-
nal repeat domains 5 and 6 (box B and C in nomenclature
of Green et al., 1992) (Nikolic et al., 1996). The first seven
amino acids lie in the B box and the rest are part of the
linker domain that is highly conserved between all plakins
(Mahoney et al., 1998; Määttä et al., 2000). The E-RC and
E-NR aggregates both associated with intermediate fila-
ments; E-RC includes the entire linker domain and E-NR
the first 11 amino acids. The distribution of the COOH
terminus of periplakin, corresponding to the intact linker,
Figure 9. Distribution of endogenous periplakin and desmoplakin in primary human keratinocytes. Cell were untreated (a–c and g) or
treated with Latrunculin B (d–f, h, and i). Red fluorescence: periplakin (PPL, detected with AE11; a, c, d, and f), desmoplakin (DP; g–i).
Green fluorescence: actin. a–c, d–f, h, and i show the same fields of cells. Bar, 6.3 mm.DiColandrea et al. Distribution of Envoplakin and Periplakin 583
was filamentous (Fig. 7 c), but that of envoplakin, compris-
ing the C box without the linker, was diffuse and punctate
(Fig. 4 f). It is therefore attractive to propose a role for the
linker in intermediate filament binding. Yeast two-hybrid
analysis of the COOH terminus of desmoplakin is consis-
tent with a role for the linker domain in the interaction of
desmoplakin with vimentin; however, for interaction with
keratins a sequence within the C box is implicated and in-
deed there is evidence from peptide competition experi-
ments that the equivalent region in envoplakin and plectin
could also be involved (Meng et al., 1997). Although more
work is required to clarify the sequences within en-
voplakin and periplakin that interact with intermediate fil-
aments, the fact that periplakin lacks a C box and yet can
associate with intermediate filaments does make the linker
domain a likely candidate. In the autoimmune disorder
paraneoplastic pemphigus autoantibodies to all the con-
ventional plakins recognize the linker domain and it is in-
teresting to speculate that this might contribute to the pa-
thology of the disease by disrupting interactions between
keratin filaments and adhesive junctions (Kiyokawa et al.,
1998; Mahoney et al., 1998).
It was previously shown that although envoplakin and
periplakin colocalize with desmoplakin at the desmosomal
plaque they are also present between desmosomes (Ma
and Sun, 1986; Ruhrberg et al., 1997). This location is
noteworthy because the interdesmosomal location is pre-
dicted to be of central importance for nucleating cornified
envelope assembly (Steinert and Marekov, 1999). Endoge-
nous periplakin at the interdesmosomal plasma membrane
was redistributed by treatment with Latrunculin B. The
transfected NH2 terminus of periplakin localized to this
site and was also sensitive to the drug. Although actin
binding sites have been identified in the NH2 terminus of
plectin and some isoforms of BPAG1 (Liu et al., 1996;
Yang et al., 1996; Fuchs et al., 1999) the predicted amino
acid sequence of periplakin, like that of desmoplakin and
envoplakin, lacks an actin binding domain. An alternative
possibility is that the interaction of periplakin with actin is
indirect, possibly via ERM proteins such as ezrin. ERM
proteins play a key role in microvillar formation (Yone-
mura et al., 1999 and references cited therein) and there is
a striking concentration of the NH2-terminal periplakin
construct at microvilli.
The first half of the NH2 terminus of periplakin was able
to localize to desmosomes and the equivalent region of
desmoplakin has the same properties (Bornslaeger et al.,
1996). In contrast, the 1/2 NH2 terminus of envoplakin had
a diffuse distribution and further experiments will there-
fore be required to identify the region of envoplakin re-
quired for targeting to desmosomes. The NH2 terminus of
desmoplakin associates with itself, with desmocollin 1a,
plakoglobin, and plakophilin 1, interactions that are im-
portant for desmosome assembly (Smith and Fuchs, 1998;
Kowalczyk et al., 1997, 1999). Plakophilin 1 contains two
functionally distinct domains, a head domain that is in-
volved in organizing the desmosomal plaque and an Arm
repeat domain that could regulate the dynamics of the ac-
tin cytoskeleton (Hatzfeld et al., 2000). There is no evi-
dence that the NH2 terminus of desmoplakin competes
with that of periplakin for desmosomal association. It will
be interesting to carry out more refined mapping of the
periplakin NH2 terminus to discover whether there are
distinct or overlapping sequences within the NH2 terminus
that target to desmosomes and microvilli.
In summary, the overall organization of periplakin and
envoplakin, as far as we have determined, is like other
plakins, with the NH2 terminus mediating membrane asso-
ciation, the rod domain dimerization and the COOH ter-
minus intermediate filament association. What makes
periplakin and envoplakin unique is their ability to het-
erodimerize, and this may be of major importance for their
role in cornified envelope assembly. Envoplakin and
periplakin can independently localize to desmosomes, but
the presence of envoplakin in the interdesmsomal mem-
brane appears to be dependent on heterodimerization
with periplakin.
Although our results lead us to propose that the NH2
terminus of periplakin could play a key role in forming the
scaffold on which the cornified envelope is assembled, the
transient transfection approach does not allow us to test
the hypothesis further. It should, instead, be possible to
use retroviral vectors to achieve sustained expression of
the periplakin and envoplakin constructs with 100% trans-
duction efficiency (Levy et al., 1998) and thereby directly
examine their role in cornified envelope assembly. One
priority will be to investigate the relationship between as-
sembly of the protein and lipid components of the enve-
lope. The lipid layer of the cornified envelope is formed
when the contents of lamellar bodies, including ceramides,
are extruded into the intercellular spaces in the upper lay-
ers of the epidermis, but it is not known whether this pre-
cedes transglutaminase cross-linking of the proteins or oc-
curs simultaneously (Nemes et al., 1999). Envoplakin and
periplakin undergo covalent attachment of ceramides
(Marekov and Steinert, 1998) in addition to isopeptide
cross-linking and transglutaminase 1 can potentially cata-
lyze both reactions (Nemes et al., 1999). By examining the
relative timing of these events and whether the proteins
associate with lamellar bodies in addition to the plasma
membrane we should gain more insight into the earliest
events in cornified envelop formation.
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